Magazine Article | August 2, 2018

Choosing A Development-Stage eCOA/ePRO Provider

Source: Life Science Leader


ISR asked study sponsors, CROs, and clinical research sites what’s the most important attribute they would use to select an eCOA (electronic clinical outcomes assessment)/ ePRO (electronic patient reported outcomes) provider for development-stage products. Since patients are often the ones navigating these applications, it is not surprising to see intuitiveness at the top of the list.